Mitigating the Emerging Threat of Mucormycosis in COVID-19
Proceedings of Singapore Healthcare
; 31(no pagination), 2022.
Article
in English
| EMBASE | ID: covidwho-2234503
artificial ventilation; coronavirus disease 2019; cytokine storm; diabetes mellitus; hospitalization; human; immunosuppressive treatment; insulin resistance; intensive care unit; letter; morbidity; mortality; mucormycosis; oxygen therapy; risk factor; angiotensin converting enzyme 2/ec [Endogenous Compound]; antibiotic agent; corticosteroid; interleukin 6/ec [Endogenous Compound]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Proceedings of Singapore Healthcare
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS